Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma

This study has been completed.

Study NCT00005951 Information provided by National Cancer Institute (NCI)

First Received: July 5, 2000 Last Updated: December 13, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given